Baden et al. 1 report on a phase 3 clinical trial of the mRNA-1273 vaccine against SARS-CoV-2, and they provide information on immediate injection-site reactions, which were observed in 84.2% of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback